Eli Lilly and Company

Senior Director Global Regulatory Lead (Early Phase) - Oncology

Chester, Maryland, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a scientific discipline, preferably in Biology, Chemistry, or a related field, and hold a Ph.D. in a relevant scientific discipline with a strong focus on oncology or a related therapeutic area. Extensive experience in drug development, including clinical trial design and execution, is required, along with a proven track record of successfully navigating regulatory pathways. Strong knowledge of global regulatory requirements, particularly within oncology, is essential, as is demonstrated leadership experience in a regulatory environment.

Responsibilities

The Senior Director Global Regulatory Lead will develop and implement innovative global regulatory strategies for oncology products, serving as the accountable decision-maker for the development and execution of these strategies. They will lead the Global Regulatory Team, creating and maintaining a highly effective team, and be responsible for the creation and maintenance of the regulatory strategy, aligning local plans with global objectives. The GRL will represent regional regulatory plans to the global brand development team and at stakeholder meetings, ensuring alignment with business priorities and managing risks. Specifically, they will lead US and Canada submissions and agency interactions for preclinical and early clinical programs, while regional regulatory scientists will handle other agency interactions. The role involves providing solutions to development and regulatory barriers, and informing development plans through collaboration with the global brand development/program team.

Skills

Regulatory Strategy
Global Regulatory Affairs
Regulatory Planning
Regulatory Risk Management
Team Leadership
Cross-functional Collaboration
Regulatory Compliance
Lifecycle Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI